Antiviral & Antifibrotic Liver Therapy in HCV + Drinkers and Non-Drinkers

NCT00211848 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Polyenylphosphatidylcholine (PPC)
DRUG: Pegylated Interferon
DRUG: Ribavirin

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]
[object Object]